Advanced Solid Tumors Clinical Trials Database - Free Access to 464 Studies
Access comprehensive clinical trial information for Advanced Solid Tumors through Pure Global AI's free database. This collection includes 464 clinical trials across multiple phases including Phase 1, Phase 1/2, Early Phase 1. Currently, 123 trials are actively recruiting participants.
Research for Advanced Solid Tumors is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
AMT-676 in Patients With Advanced Solid Tumors
A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors
The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
An Evaluation of BAT 8010 for Injection in Combination With BAT 1006 in Locally Advanced or Metastatic Entities Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of the Tumor in Patients Multicenter, Open Phase Ib/IIa Clinical Study
BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors
Phase 1 Trial of KH801
A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
HS-20089 Combination Treatment in Subjects With Advanced Solid Tumors
A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors
A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
A Study for HSK39775 in Participants With Solid Tumors
Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors
A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors
Study of ACR246 in Advanced Solid Tumors
A First-in-human Study of GENA-104A16 in Patients With Advanced Solid Tumors
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
Pure Global AI provides free access to 464 clinical trials studying Advanced Solid Tumors, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Novartis Pharmaceuticals, Pfizer, Bristol-Myers Squibb, among others.